May 2007
Volume 48, Issue 13
ARVO Annual Meeting Abstract  |   May 2007
Urokinase Receptor Cleavage: A Crucial Step in Fibroblast to Myofibroblast Differentiation
Author Affiliations & Notes
  • A. M. Bernstein
    Ophthalmology, Mount Sinai School of Medicine, New York, New York
  • S. S. Twining
    Biochemistry, Medical College of Wisconsin, Milwaukee, Wisconsin
  • D. J. Warejcka
    Biochemistry, Medical College of Wisconsin, Milwaukee, Wisconsin
  • E. Tall
    Ophthalmology, Mount Sinai School of Medicine, New York, New York
  • S. K. Masur
    Ophthalmology, Mount Sinai School of Medicine, New York, New York
  • Footnotes
    Commercial Relationships A.M. Bernstein, None; S.S. Twining, None; D.J. Warejcka, None; E. Tall, None; S.K. Masur, None.
  • Footnotes
Investigative Ophthalmology & Visual Science May 2007, Vol.48, 1498. doi:
  • Views
  • Share
  • Tools
    • Alerts
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      A. M. Bernstein, S. S. Twining, D. J. Warejcka, E. Tall, S. K. Masur; Urokinase Receptor Cleavage: A Crucial Step in Fibroblast to Myofibroblast Differentiation. Invest. Ophthalmol. Vis. Sci. 2007;48(13):1498.

      Download citation file:

      © ARVO (1962-2015); The Authors (2016-present)

  • Supplements

Purpose:: In corneal fibroblasts, uPA binding to uPAR (urokinase plasmingen activator and its receptor) localizes an extracellular protease system that promotes matrix remodeling, growth factor activation, and migration in response to wounding. PAI-1 (plasminogen activator inhibitor) is a multifunctional molecule that promotes the internalization of uPA/uPAR and integrins from the cell surface through the binding of the LRP receptor. We have investigated the role of the uPA/uPAR/PAI-1 pathway in myofibroblast differentiation since control of myofibroblast differentiation from fibroblasts is critical for regenerative wound healing.

Methods:: Human corneal fibroblasts (HCFs) were cultured on collagen or vitronectin in supplemented serum free media for 3 days with 10µg/ml FGF-2/heparin or 1ng/ml TGFß1 to regulate fibroblast and myofibroblast phenotypes, respectively. PAI-1 and uPAR expression were evaluated by western blot and immunofluoresence. To study the role of uPAR on myofibroblast differentiation, HCFs were transfected with a non-cleavable form of uPAR prior to TGFß1 treatment and evaluated by immunocytochemical detection of α-smooth muscle actin (α-SMA) as a marker of myofibroblast differentiation.

Results:: uPAR cleavage and PAI-1 were critical to myofibroblast differentiation. Cleavage of uPAR’s N-terminal domain (D1), resulting in a truncated form of uPAR (D2D3) on the myofibroblast’s surface, was required for myofibroblast differentiation since 1) protease inhibitors that prevented uPAR cleavage, also prevented myofibroblast differentiation and 2) over-expression of a non-cleavable uPAR cDNA inhibited myofibroblast differentiation. In addition, PAI-1 and integrin in combination with matrix played a role in mediating myofibroblast differentiation. Myofibroblast differentiation on vitronectin, as indicated by incorporation of α-SMA into stress fibers, required the removal of PAI-1 from the HCFs’ surface and addition of Mn2+ to activate integrins.

Conclusions:: These data support the novel hypothesis that uPAR cleavage and PAI-1 expression contribute to the mechanism underlying the fibroblast to myofibroblast transition.

Keywords: cornea: stroma and keratocytes • proteolysis • wound healing 

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.